Friday, December 10, 2010 |
| 16.00 - 19.00 |
Registration |
Saturday, December 11, 2010 |
| 08:00 - 08:10 |
Welcome and Introduction
E. Akriviadis, Greece |
| 08:10 - 10:00 |
Symposium 1: Epidemiologic Trends of Alcoholic Liver Disease in Europe
Chairpersons: G. Addolorato, Italy
D. Leon, UK |
| 08:10 - 08:30 |
Epidemiologic Trends in Mortality from Liver Cirrhosis and Other Alcohol-Related Conditions in Western and Eastern Europe
D. Leon, UK |
| 08:30 - 08:50 |
Genetics of alcohol abuse and ALD
M. Marcos Martin, Spain |
| 08:50 - 09:10 |
Alcohol Abuse as a Co-factor for Other Types of Liver Diseases
H. K. Seitz, Germany |
| 09:10 - 09:30 |
Increasing Burden of Alcoholic Liver Disease in Europe: Need for Action
H. Cortez-Pinto, Portugal |
| 09:30 - 09:50 |
Drinking Patterns and the Risk of Alcohol Related Liver Disease
N. Sheron, UK |
| 09:50 - 10:10 |
Panel Discussion |
| 10:10 - 10:40 |
State of the Art Lecture 1
Current Evaluation and Management of Patients with Alcohol Dependence
A. Gual, Spain
Presented By: R. Bataller, Spain |
| 10:40 - 11:00 |
Coffee Break |
| 11:00 - 13:05 |
Symposium 2: Pathogenesis of Alcoholic Liver Disease
Chair: F. Marra, Italy |
| 11:00 - 11:25 |
Is ALD Immune-mediated?
B. Gao, USA |
| 11:25 - 11:50 |
Oxidative Stress and Hepatocellular Injury
J. C. Fernandez-Checa, Spain |
| 11:50 - 12:15 |
Inflammatory Pathways in ALD
G. Szabo, USA |
| 12:15 - 12:40 |
Novel Pathways Involved in Fibrogenesis in ALD
S. Lotersztajn, France |
| 12:40 - 13:05 |
Impact of Obesity on ALD: Underlying Mechanisms
H. Tsukamoto, USA |
| 13:05 - 14:30 |
Lunch break and Poster Viewing |
| 14:30 - 16:20 |
Symposium 3: Fibrosis Progression and Evaluation of Alcoholic Liver Disease
Chair: M. Thursz, UK |
| 14:30 - 14:50 |
Natural History of ALD: Risk Factors of Fibrosis Progression
C. Day, UK |
| 14:50 - 15:10 |
Clinical Course of Alcoholic Cirrhosis
P. Jepsen, Denmark |
| 15:10 - 15:30 |
Invasive and Non-invasive Evaluation of Disease Progression in ALD
M. Pinzani, Italy |
| 15:30 - 15:50 |
Genetics of Liver Injury and Fibrosis
F. Lammert, Germany |
| 15:50 - 16:20 |
Panel Discussion |
| 16:20 - 16:50 |
Coffee Break and Poster Viewing |
| 16:50 - 19:00 |
Symposium 4: Alcoholic Hepatitis
Chair: E. Akriviadis, Greece |
| 16:50 - 17:10 |
Identification of New Targets with Translational Research
R. Bataller, Spain. |
| 17:10 - 17:30 |
How to Use Prognostic Models in the Management of Patients with Alcoholic Hepatitis
E. Forrest, UK |
| 17:30 - 17:50 |
Systemic Inflammatory Response and Alcoholic Hepatitis
R. Jalan, UK |
| 17:50 - 18:10 |
Medical Therapy in Patients with Severe Forms: Future Challenges
P. Mathurin, France |
| 18:10 - 19:00 |
Panel Discussion |
| 19:00 - 20:00 |
Welcome Reception and Poster Viewing |
Sunday December 12, 2010 |
| 08:00 - 09:50 |
Symposium 5: Medical Management of Alcoholic Liver Disease
Chair: B. Runyon, USA |
| 08:00 - 08:20 |
Medical Management of Decompensated ALD
B. Runyon, USA |
| 08:20 - 08:40 |
Intensive Care in Patients with Life - Threatening ALD
B. Cook, UK |
| 08:40 - 09:00 |
Nutrition Support and ALD
J. Caballeria, Spain |
| 09:00 - 09:20 |
ALD as a Multidisciplinary Systemic Disease
J. Fernández-Solà, Spain |
| 09:20 - 09:50 |
Panel Discussion |
| 09:50 - 10:20 |
State of the Art Lecture 2
Can we Stop Fibrosis Progression in Patients with ALD?
S. Friedman, USA
Presented By: P. Mathurin, France |
| 10:20 - 10:50 |
Coffee Break and Poster Viewing |
| 10:50 - 12:40 |
Symposium 6: Liver Transplantation in Patients with ALD
Chair: F. Stickel, Switzerland |
| 10:50 - 11:10 |
Liver Transplantation in Alcoholic Cirrhosis: an Update
M. Lucey, USA |
| 11:10 - 11:30 |
How to Select Alcoholic Patients as Candidates for Liver Transplantation?
G-P. Pageaux, France |
| 11:30 - 11:50 |
Impact of Alcohol Relapse After Liver Transplantation
P. Burra, Italy |
| 11:50 - 12:10 |
Liver Transplantation for Alcoholic Hepatitis
A. K. Burroughs, UK |
| 12:10 - 12:40 |
Panel Discussion |
| 12:40 - 14:30 |
Lunch Break and Poster Viewing |
| 14:30 - 16:20 |
Symposium 7: Future Prospects in Alcoholic Liver Disease
Chair: S. P. Dourakis, Greece |
| 14:30 - 14:50 |
Stem Cell - Based Therapy in ALD
T. Roskams, Belgium |
| 14:50 - 15:10 |
Future Therapies in ALD: Where are we Going?
A. Hadengue, Switzerland |
| 15:10 - 15:30 |
Optimum Strategy for Society to Confront the Increasing Burden of Alcoholic Liver Disease
B. Ritson, UK |
| 15:30 - 15:50 |
What are the Main Unmet Needs in ALD?
D-C. Valla, France |
| 15:50 - 16:20 |
Panel Discussion |
| 16:20 - 16:30 |
Concluding Remarks
E. Forrest, UK |